Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 31 October 2013 | By Louise Zornoza,
China's Food and Drug Administration (CFDA) recently issued revised Good Supply Practice (GSP) guidance for pharmaceutical cold chain quality control requirements that addresses computer systems, automatic temperature and humidity monitoring, drug delivery and acceptance and validation management.
In issuing the revised guidance on 23 October 2013, CFDA said it draws extensively on the drug distribution regulatory policies of the World Health Organization (WHO) and "some developed countries and regions." The agency also drew on China's pharmaceutical good manufacturing practice (GMP) experience, keeping in mind that the overall infrastructure for management of pharmaceutical distribution in the country is weak.
CFDA acknowledged that implementation of the proposed new management measures and new technical requirements, while necessary, will not be easy.
CFDA: GSP Guidance
Read all Breaking News from RegLink
Regulatory Focus newsletters
All the biggest regulatory news and happenings.